Mettler-Toledo Started at 'Sell' by Redburn on Valuation Concerns

Redburn initiated coverage of precision instrument manufacturer Mettler-Toledo with a 'Sell' rating on Wednesday, arguing the company's premium stock valuation is misaligned with a future of moderating growth and intensifying competition. The brokerage set a price target of $1,200, which implies approximately 15% downside from the company's share price of $1,405 cited in the report.

Valuation Outpaces Growth

Redburn's central concern is that Mettler-Toledo's stock is trading at a significant premium that its future growth may not support. The firm noted the shares are valued at about 27 times its 2027 expected earnings, a level above its global life-science tools peers that leaves limited room for further multiple expansion.

The brokerage argued that while the company has a strong market position, its mature end markets, increasing commoditization, and persistent pressure in China could constrain future growth and pricing power. Redburn forecasts medium-term group revenue growth of only 4.8% and expects its adjusted earnings per share (EPS) estimates to remain 1%-3% below consensus from 2027 through 2029.

Competitive and Market Headwinds

According to Redburn, Mettler-Toledo's core laboratory and weighing markets are growing at a modest pace of only 3%-4% annually. The firm sees increasing pressure on pricing as competitors improve product quality and narrow technological gaps.

Ad

Key challenges highlighted by the brokerage include:

• Industrial Weighing: This segment, representing 39% of revenue, is seen as particularly exposed to competition as customers are more price-sensitive.
• Chinese Competition: Manufacturers in China are becoming more competitive, especially at the lower end of the weighing market.
• China Exposure: The country accounts for 16% of group revenue, a higher proportion than the 10% peer average, adding a source of persistent pressure.

Acknowledged Strengths

Despite the bearish rating, Redburn acknowledged Mettler-Toledo's fundamental strengths. The firm described the company's returns as "best-in-class," with a return on invested capital (ROIC) of approximately 28%. Other positive factors include a strong brand, a large installed base of instruments, and a growing services business.

The services division, which includes calibration, maintenance, and certification contracts, provides a resilient revenue stream, now representing about 25% of group revenue. Redburn also identified the Process Analytical Technology (PAT) business as a high-growth segment, expanding at about 13% annually due to its integration into regulated biopharma manufacturing, which creates high switching costs for customers.